Does genetic variation in the Δ6-desaturase promoter modify the association between α-linolenic acid and the prevalence of metabolic syndrome?

dc.creator	Truong, Hong
dc.creator	DiBello, Julia R.
dc.creator	Ruiz Narváez, Edward A.
dc.creator	Kraft, Peter
dc.creator	Campos Núñez, Hannia
dc.creator	Baylin, Ana
dc.date.accessioned	2025-05-29T16:41:25Z
dc.date.available	2025-05-29T16:41:25Z
dc.date.issued	2009
dc.description.abstract	Background: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are associated with protection against components of the metabolic syndrome, but the role of α-linolenic acid (ALA), the metabolic precursor of EPA and DHA, has not been studied. The Δ6-desaturase enzyme converts ALA into EPA and DHA, and genetic variation in the Δ6-desaturase gene (FADS2) may affect this conversion.	en_CR
dc.description.pages	920-925
dc.description.uri	https://sibdi.ucr.ac.cr/formulario-transferencia-digital-ccp/	es_CR
dc.identifier.issn	1938-3207
dc.identifier.uri	https://repositorio.sibdi.ucr.ac.cr/handle/123456789/24852
dc.language.iso	en	en_CR
dc.publisher	The American Journal of Clinical Nutrition, Vol.89, no. 3
dc.subject	ENFERMEDADES CARDIOVASCULARES	es_CR
dc.subject	METABOLISMO	es_CR
dc.title	Does genetic variation in the Δ6-desaturase promoter modify the association between α-linolenic acid and the prevalence of metabolic syndrome?	en_CR
dc.type	Article

Files

Now showing 1 - 1 of 1